论文部分内容阅读
病例和方法:哮喘患者(哮喘组)21例,男12例,女9例,年龄26～67岁。慢性喘息性支气管炎患者(喘支组)18例,男13例,女5例,年龄35～66岁。慢性单纯性支气管炎患者(慢支组)24例,男16例,女8例,年龄41～78岁。健康对照组50例,男24名,女26名,年龄19～42岁。IgD 测定方法用单向免疫扩散法。结果:血清IgD 含量(Iμ/ml)在哮喘组((?)±s=162.4±61.7)和喘支组(147.3±72.4)明显高于对照组(34.9±33.2,P<0.001),慢支组(67.5±43.1)亦高于对照组(P<0.05),但哮喘组和喘支组的血清IgD 含量与慢支组比较
Cases and Methods: 21 cases of asthma patients (asthma group), 12 males and 9 females, aged 26 to 67 years old. Chronic asthmatic bronchitis patients (asthma group) in 18 cases, 13 males and 5 females, aged 35 to 66 years. Chronic simple bronchitis patients (chronic bronchitis group) 24 cases, 16 males and 8 females, aged 41 to 78 years. Healthy control group of 50 patients, 24 males and 26 females, aged 19 to 42 years. IgD determination using one-way immunodiffusion. Results: Serum IgD levels in asthma group (±? = 162.4 ± 61.7) and asthma group (147.3 ± 72.4) were significantly higher than those in control group (34.9 ± 33.2, P <0.001) Group (67.5 ± 43.1) was also higher than the control group (P <0.05), but the serum IgD levels in asthmatic group and asthmatic group were significantly higher than those in chronic bronchitis group